생명과학회지 (Journal of Life Science)

  • 제19권3호
  • /
  • Pages.327-333
  • /
  • 2009
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

건선(psoriasis)에서 혈관내피 성장인자(VEGF)에 대한 acitretin의 효과

The Effect of Acitretin to the Expression of Vascular Endothelial Growth Factor in Psoriasis

  • 김지연 (경상대학교 의과대학 피부과학교실 & 의학연구소) ;
  • 김성민 (경상대학교 의과대학 피부과학교실 & 의학연구소) ;
  • 김군도 (부경대학교 자연과학대학 미생물학과)
  • Kim, Chi-Yeon (Department of Dermatology, School of Medicine, Gyeongsang National University, Gyeongsang Institute of Health Science) ;
  • Kim, Seong-Min (Department of Dermatology, School of Medicine, Gyeongsang National University, Gyeongsang Institute of Health Science) ;
  • Kim, Gun-Do (Department of Microbiology, College of Natural Sciences, Pukyong National University)
  • 발행 : 2009.03.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

건선(psoriasis)은 각화(keratinization)의 장애에 의한 질병으로 잘 알려져 있다. 이 질병에있어서, 몇몇 보고에 따르면 피부 미세혈관이 증가되고, 혈관 신생 유도 인자들인 내피 성장 인자(VEGF) 및 섬유아세포 성장 인자(bFGF)가 과발현된다고 보고 되어져 있다. 신생혈관(angiogenesis)은 건선의 진행성에 있어 중요한 역할을 할지도 모른다. Acitretin은 keratinocyte 성장과 분화에 그것의 잠재적인 활동 때문에 anti-psoriatic 약으로 널리 이용된다. 그러나 신생혈관에 대한 효과는 여전히 불명확하다. 본 면역혈청학적 연구 목표는 건선염 피부에 있는 VEGF의 발현에 acitretin의 효과를 조사하기 위한 것이었다. 우리는 10명의 건선염 피부환자와 대조군으로 3명의 정상인 피부에 acitretin의 치료 전과 후의 VEGF의 발현량을 비교하였다. 치료 전 대조군인 정상인 피부에서보다 건선염 피부환자에서 VEGF의 발현은 명백히 높은 수준이었다. 건선염 피부환자에서 VEGF의 발현량은 acitretin 치료 후 치료 전과 비교시 감소되었다. Acitretin은 건선 피부에서 VEGF와 같은 혈관 신생 유도 인자의 발현을 감소 시켜 신생혈관형성에 있어 억제의 효과가 있음을 나타낸다. 우리는 신생혈관 관점에서 acitretin이 건선에 대한 치료 수단이 될 수 있다는 것을 제안한다.

Psoriasis is a well known disorder of keratinization. In this disease, several reports revealed that dermal micro vessels are increased and angiogenic factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) are over-expressed. Angiogenesis may play an important role in the progression of psoriasis. Acitretin is widely used as an anti-psoriatic drug because of its potent action on keratinocyte growth and differentiation, but its effects on angiogenesis are uncertain. The goal of this immunohistochemical study was to investigate the effects of acitretin on the expression of VEGF in psoriatic lesions of the skin. We compared the expression levels of VEGF between pre- and post-acitretin treated skin - 10 psoriatic skin lesions and 3 normal (control) skins. The expressions of VEGF in psoriatic skin lesions were significantly higher than in normal control skin. The expressions of VEGF in psoriatic skin lesions post-treatment were lower than those pre-treatment. Acitretin revealed inhibitory effects on angiogenesis by reducing the expression of angiogenic factors such as VEGF in psoriatic skin lesions. We suggest that acitretin may be useful in therapeutic approaches to psoriasis management, possibly related to angiogenesis.

키워드

참고문헌

  1. Anderson, T. F. and J. Woorhees. 1986. Psoriasis. pp. 67-84, In Thiers, B. and W. Dobson (eds.), Pathogenesis of skin disease. McGraw-Hill book, New York
  2. Berse, B., L. F. Brown, L. Van De Water, H. F. Dvorak, and D. R. Senger. 1992. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 3, 211-220 https://doi.org/10.1091/mbc.3.2.211
  3. Braunhut, S. J. and M. A. Moses. 1994. Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP). J. Biol. Chem. 269, 13472-13479
  4. Braverman, I. M. and A. Keh-Yen. 1986. Three-dimensional reconstruction of endothelial cell gaps in psoriatic vessels and their morphologic identity with gaps produced by the intradermal injection of histamine. J. Invest. Dermatol. 86, 577-581 https://doi.org/10.1111/1523-1747.ep12355222
  5. Camacho, L. H. 2003. Clinical applications of retinoids in cancer medicine. J. Biol. Regul. Homeost. Agents. 17, 98-114
  6. Christopher, F. and G. G. Krueger. 1987. Psoriasis. pp. 461-491, In Fitzpatrick, T. B., A. Z. Eisen, and D. Wolff (eds.), Dermatology in general medicine, 3rd ed, MaGraw-Hill Book, New York
  7. Christophers, E., R. Parzefall, and O. Braun-Falco. 1973. Initial events in psoriasis: quantitative assessment. Br. J. Dermatol. 89, 327-334 https://doi.org/10.1111/j.1365-2133.1973.tb02986.x
  8. Detmar, M., L. F. Brown, K. P. Claffey, K. T. Yeo, O. Kocher, R. W. Jackman, B. Berse, and H. F. Dvorak. 1994. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med. 180, 1141-1146 https://doi.org/10.1084/jem.180.3.1141
  9. Detmar, M., K. T. Yeo, J. A. Nagy, L. Van de Water, L. F. Brown, B. Berse, B. M. Elicker, S. Ledbetter, and H. F. Dvorak. 1995. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J. Invest. Dermatol. 105, 44-50 https://doi.org/10.1111/1523-1747.ep12312542
  10. Diaz, B. V., M. C. Lenoir, A. Ladoux, C. Frelin, M. Demarchez, and S. Michel. 2000. Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids. J. Biol. Chem. 275, 642-650 https://doi.org/10.1074/jbc.275.1.642
  11. Dvorak, H. F., L. F. Brown, M. Detmar, and A. M. Dvorak. 1995. Vascular permeability factor/ vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146, 1029-1039
  12. Edward, R. S., N. Mark, C. W. James, K. S. Andres, L. Samuel, and H. Meenhard. 1999. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin. Cancer Res. 5, 775-782
  13. Ferrara, N. 1999. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int. 56, 794-814 https://doi.org/10.1046/j.1523-1755.1999.00610.x
  14. Folkman, J. and M. Klagsburn. 1987. Angiogenic factors. Science 235, 442-447 https://doi.org/10.1126/science.2432664
  15. Gille, J., M. Khalik, V. Konig, and R. Kaufmann. 1998. Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes. J. Invest. Dermatol. 111, 1160-1165 https://doi.org/10.1046/j.1523-1747.1998.00418.x
  16. Gottlieb, A. B. 1997. Immunopathogenesis of psoriasis. Arch. dermatol. 133, 781-782 https://doi.org/10.1001/archderm.133.6.781
  17. Ishikawa, F, K. Miyazono, and U. Hellman. 1989. Identification of anangiogenic activity and the cloning and expression of platelet derived endothelial cell growth factor. Nature 338, 557-562 https://doi.org/10.1038/338557a0
  18. Kini, A. R., L. A. Peterson, M. S. Tallman, and M. W. Lingen. 2001. Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid. Blood 97, 3919-3924 https://doi.org/10.1182/blood.V97.12.3919
  19. Koch, A. E., P. J. Polverini, S. L. Kunkel, L. A. Harlow, L. A. DiPietro, V. M. Elner, S. G. Elner, and R. M. Strieter. 1992. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 58, 1798-1801
  20. Kuroda, K., A. Sapadin, T. Shoji, R. Fleischmajer, and M. Lebwohl. 2001. Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. J. Invest. Dermatol. 116, 713-720 https://doi.org/10.1046/j.1523-1747.2001.01316.x
  21. Lachgar, S., M. Charveron, Y. Gall, and J. L. Bonafe. 1999. Inhibitory effects of retinoids on vascular endothelial growth factor production by cultured human skin keratinocytes. Dermatology 199, 25-27 https://doi.org/10.1159/000051374
  22. Lansink, M, P. Koolwijk, V. van Hinsbergh, and T. Kooistra. 1998. Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression. Blood 92, 927-938
  23. Larcher, F., R. Murillas, M. Bolontrade, C. J. Conti, and J. L. Jorcano. 1998. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene17, 303-311 https://doi.org/10.1038/sj.onc.1201928
  24. Lingen, M. W., P. J. Polverini, and N. P. Bouck. 1996. Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic. Am. J. Pathol. 149, 247-258 https://doi.org/10.1016/S1368-8375(00)00090-7
  25. Mordovtsev, V. N. and V. I. Albanova. 1989. Morphology of skin microvasculature in psoriasis. Am. J. Dermatopathol. 11, 33-42 https://doi.org/10.1097/00000372-198902000-00006
  26. Neufeld, G., T. Cohen, S. Gengrinovitch, and A. Poltorak. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9-22 https://doi.org/10.1096/fasebj.13.1.9
  27. Nickoloff, B. J., R. S. Mitra, J. Varani, V. M. Dixit, and P. J. Polverini. 1994. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am. J. Pathol. 44, 820-828
  28. Pal, S., M. L. Iruela-Arispe, V. S. Harvey, H. Zeng, J. A. Nagy, H. F. Dvorak, and D. Mukhopadhyay. 2000. Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade. Microvasc. Res. 60, 112-120 https://doi.org/10.1006/mvre.2000.2246
  29. Senger, D. R., K. P. Claffey, J. E. Benes, and C. A. Perruzzi, A. P. Sergiou, and M. Detmar. 1997. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc. Natl. Acad. Sci.USA 94, 13612-13617 https://doi.org/10.1073/pnas.94.25.13612
  30. Weninger, W., M. Rendl, M. Mildner, and E. Tschachler. 1998. Retinoids downregulate vascular endothelial growth factor/vascular permeability factor production by normal human keratinocytes. J. Invest. Dermatol. 111, 907-911 https://doi.org/10.1046/j.1523-1747.1998.00393.x